Vishala T. Neppalli

Hematology

565 Abbott Rd
Buffalo, NY 14220

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study.

Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study.

Journal: Cancer

Published: August 26, 2021

Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia.

Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia.

Journal: Frontiers in oncology

Published: March 01, 2021

Multiple painful ulcerated lesions in a 73-year-old patient.

Multiple painful ulcerated lesions in a 73-year-old patient.

Journal: Oral surgery, oral medicine, oral pathology and oral radiology

Published: January 08, 2021

Next-Generation Sequencing Delineates Clonal Origins and Informs Therapeutic Strategies in Acute Lymphoblastic Leukemia and Histiocytic Sarcoma.

Next-Generation Sequencing Delineates Clonal Origins and Informs Therapeutic Strategies in Acute Lymphoblastic Leukemia and Histiocytic Sarcoma.

Journal: JCO precision oncology

Published: December 01, 2019

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019.

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: January 20, 2019

Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity.

Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: August 04, 2018

Radiological imaging and bone marrow biopsy in staging of cutaneous B-cell lymphoma.

Radiological imaging and bone marrow biopsy in staging of cutaneous B-cell lymphoma.

Journal: British journal of haematology

Published: February 23, 2018

All-trans-retinoic-acid and arsenic trioxide induced remission in promyelocytic blast crisis.

All-trans-retinoic-acid and arsenic trioxide induced remission in promyelocytic blast crisis.

Journal: Leukemia research reports

Published: February 17, 2018

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: January 04, 2018

TAFRO syndrome: A case report and review of the literature.

TAFRO syndrome: A case report and review of the literature.

Journal: Human pathology (New York)

Published: November 01, 2017

A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma.

A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: August 17, 2017

Anaplastic Multiple Myeloma: An Aggressive Variant With a Poor Response to Novel Therapies.

Anaplastic Multiple Myeloma: An Aggressive Variant With a Poor Response to Novel Therapies.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 15, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026